Found: 33
Select item for more details and to access through your institution.
The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 331, doi. 10.3390/ph13110331
- By:
- Publication type:
- Article
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study.
- Published in:
- Environmental Health: A Global Access Science Source, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12940-024-01070-6
- By:
- Publication type:
- Article
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 474, doi. 10.3390/vaccines12050474
- By:
- Publication type:
- Article
Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 689, doi. 10.3390/vaccines9070689
- By:
- Publication type:
- Article
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231222604
- By:
- Publication type:
- Article
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113278
- By:
- Publication type:
- Article
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035710
- By:
- Publication type:
- Article
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035710
- By:
- Publication type:
- Article
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cardiorespiratory coupling is associated with exercise capacity in patients with chronic obstructive pulmonary disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5095, doi. 10.3390/cancers14205095
- By:
- Publication type:
- Article
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143470
- By:
- Publication type:
- Article
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 977, doi. 10.3390/cancers14040977
- By:
- Publication type:
- Article
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 316, doi. 10.3390/cancers14020316
- By:
- Publication type:
- Article
Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 4, p. 626, doi. 10.1002/ijc.33821
- By:
- Publication type:
- Article
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Overall Response to First-Line Tyrosine Kinase Inhibitor and Second-Line Chemotherapy Is Predictive of Survival Outcome in Epidermal Growth Factor Receptor-Mutated Adenocarcinoma.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 201, doi. 10.1159/000371735
- By:
- Publication type:
- Article
Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 7, p. 529, doi. 10.1111/1759-7714.15212
- By:
- Publication type:
- Article
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR‐mutated NSCLC treated with afatinib.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 25, p. 2548, doi. 10.1111/1759-7714.15017
- By:
- Publication type:
- Article
Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 1, p. 12, doi. 10.1111/1759-7714.14537
- By:
- Publication type:
- Article
The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 4, p. 348, doi. 10.1111/1759-7714.14674
- By:
- Publication type:
- Article
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 13, p. 1888, doi. 10.1111/1759-7714.14272
- By:
- Publication type:
- Article
Front‐line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 12, p. 2274, doi. 10.1111/1759-7714.13221
- By:
- Publication type:
- Article
Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 8, p. 1683, doi. 10.1111/1759-7714.13125
- By:
- Publication type:
- Article
Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 5, p. 1158, doi. 10.1111/1759-7714.13057
- By:
- Publication type:
- Article
Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR‐mutant and EGFR‐wild type nonsquamous non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 12, p. 1648, doi. 10.1111/1759-7714.12875
- By:
- Publication type:
- Article
The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma.
- Published in:
- Biomedicines, 2020, v. 8, n. 2, p. 36, doi. 10.3390/biomedicines8020036
- By:
- Publication type:
- Article
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 2, p. 195, doi. 10.1007/s11523-023-00946-w
- By:
- Publication type:
- Article
Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2022, p. 1, doi. 10.1177/17534666221132731
- By:
- Publication type:
- Article
Bronchoscopic debulking for endobronchial malignancy: Predictors of recanalization and recurrence.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 6, p. 722, doi. 10.1111/1759-7714.12248
- By:
- Publication type:
- Article
A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 489, doi. 10.1007/s40487-021-00152-6
- By:
- Publication type:
- Article